HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--Feb. 17, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to announce that the results from the successfully completed clinical studies of the Company’s saliva version of the NicAlert(TM) test for tobacco exposure will be presented this week at the 12th Annual Meeting of the Society for Research on Nicotine and Tobacco (SRNT) in Orlando, FL. The Society currently has over a thousand members, including many of the top experts on nicotine and tobacco from over 20 countries around the world. The presentation of the NicAlert(TM) saliva study results will be made by Dr. Norman J. Montalto, one of the principal investigators in the studies. Dr. Montalto is a clinical expert in the field of tobacco use and dependency, and is Professor in the Department of Family Medicine at West Virginia University in Charleston, WV, and Director of the Freedom from Tobacco Use Program in Charleston.
